ArticleNeuro-oncology practice2022

Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?

Quirien Oort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.